Is Lorlatinib a targeted drug?

Lorlatinib (Lorlatinib) is a targeted drug specifically designed to treat patients with a specific type of lung cancer, namely ALK (tyrosine kinase) and ROS1 positive non-small cell lung cancer (NSCLC). Targeted drugs are a class of drugs that target specific molecules or signaling pathways in cancer cells. Their mechanism of action is different from traditional chemotherapy drugs in that they are designed to more precisely interfere with the growth and spread of cancer cells while minimizing damage to healthy cells.

Lolatinib's main role is to target ALK and ROS1 fusion gene mutations, which are very common in some NSCLC patients. These gene mutations lead to abnormal activation of related signaling pathways in tumor cells, thereby promoting uncontrolled proliferation and spread of cancer cells. Lorlatinib effectively blocks these abnormal signaling by inhibiting the activity of ALK and ROS1 proteins, thereby inhibiting the growth of cancer cells.

Lorlatinib not only targetsALK and ROS1 but has also shown efficacy against some drug-resistant mutations. This means that even if patients develop resistance to other ALK inhibitors, they may still benefit from treatment with lorlatinib. This multi-targeting property makes lorlatinib a powerful tool for the treatment of specific subtypes of NSCLC.

Lorlatinib has shown significant efficacy in multiple clinical trials. For ALK and ROS1 positive NSCLC patients, it often provides longer progression-free survival and better quality of life. This offers new therapeutic hope for these patients, especially those who have previously developed resistance to other treatments.

Lorlatinib has been launched in China and is included in medical insurance. Patients can purchase it domestically, but the price is relatively high, about 10,000 to 20,000 yuan. For details, please consult the local hospital pharmacy. There are original drugs and cheaper generic drugs abroad. The cheaper ones are the original drugs from Turkey, which cost more than 1,000 yuan, and the original drugs from Hong Kong, China, which cost about 30,000 yuan. Generic drugs are mainly generic drugs from Laos and Bangladesh. The price is about several thousand yuan, and the ingredients of the original drugs and generic drugs are basically the same.